Observational studyLung cancer (Amsterdam, Netherlands)2025

Outcomes with neoadjuvant osimertinib and/or chemotherapy in patients with EGFR-mutant resectable non-small cell lung cancers.

Prashasti Agrawal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.